MedEdTalks - Ophthalmology

In this podcast, expert clinicians will discuss newer therapies and treatment regimens that have demonstrated efficacy in the management of dry eye and ocular surface disease.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241206/3-ocular-surface-and-eyelid-health-unlocking-new-therapies-for-ded

In this podcast, expert clinicians will discuss treatment regimens and management strategies that improve outcomes for patients with ocular surface, dry eye, and eyelid margin diseases. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241206/1-ocular-surface-and-eyelid-health-unveiling-the-lid

In this podcast, expert clinicians will discuss treatments with new mechanisms of action, ongoing clinical trials, and the latest data regarding advances in vitreoretinal care. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241210/11-the-retina-radar-with-dr-arshad-khanani-emerging-therapeutics-in-late-stage-development

In this podcast, expert clinicians will discuss the latest FDA guidance regarding clinical trial designs for nAMD treatment.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241210/12-the-retina-radar-with-dr-arshad-khanani-new-fda-draft-guidance-for-namd-trials

In this podcast, expert clinicians will discuss treatment regimens and management strategies that have shown to improve outcomes for patients with meibomian gland dysfunction and Demodex blepharitis. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241206/2-ocular-surface-and-eyelid-health-demystifying-demodex-and-mgd

In this podcast, expert clinicians will discuss ongoing clinical trials and the latest data regarding advances in vitreoretinal care.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20241210/13-the-retina-radar-with-dr-arshad-khanani-retina-radar-recap

In this podcast, expert clinicians will discuss practices, procedures, and treatments that can improve the detection and treatment of ocular surface and dry eye disease.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241211/1-ocular-surface-and-lid-health-collaborative-care-a-focus-on-dry-eye-disease

In this podcast, expert clinicians will discuss interprofessional approaches that can increase efficiency and improve ocular surface and lid health in patients.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241211/3-ocular-surface-and-lid-health-collaborative-care-a-focus-on-collaborative-practice

In this podcast, expert clinicians will discuss practices, procedures, and treatments that can improve the detection and treatment of ocular surface disease and Demodex blepharitis.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241211/2-ocular-surface-and-lid-health-collaborative-care-a-focus-on-lid-health

Geographic atrophy (GA) is a progressive, degenerative disease whose development is associated with modifiable and nonmodifiable risk factors, including mutations in specific genes involved in the regulation of the complement system. Multimodal imaging is crucial for the early diagnosis and determination of GA progression, with current recommendations highlighting optical coherence tomography as the primary imaging modality for detecting biomarkers associated with progression. Two novel therapies that target components of the complement system were approved by the FDA in 2023 allowing for personalized, long-term management of GA. In this CE activity, experts in the field review the latest imaging tools for the early diagnosis and monitoring of disease progression; evaluate clinical and imaging characteristics associated with disease progression in different phenotypes; and assess individualized treatment selection for patients with GA secondary to age-related macular degeneration (AMD). Rapid-Fire Roundtable discussion will further examine practical methods and procedures that can facilitate the optimal implementation of imaging modalities and therapies into the management of patient with GA secondary to AMD.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/ophthalmology/20241202/ga-secondary-to-amd-optimizing-long-term-outcomes-through-refined-treatment-selection